MarketResearch.com Announces Release of “2015-16 Induced Pluripotent Stem … – PR Newswire (press release)
|
MarketResearch.com Announces Release of “2015-16 Induced Pluripotent Stem …
PR Newswire (press release) The report is targeted to serve the management of stem cell product and therapy companies, as well as stem cell industry investors. Because iPSCs were discovered in 2006, the global market for iPSC products celebrated its 10th year of existence in 2015. |
Livemint |
Stempeutics receives EU orphan drug designation for novel stem cell drug
Business Standard The European Medicines Agency (EMA) has granted orphan drug designation (ODD) for Stempeutics Research’s novel stem cell drug Stempeucel used in the treatment of thromboangiitis obliterans. The Bangalore-based Stempeutics Research is a group … Stempeutics eyes late-stage trial waiver for stem–cell drugLivemint Stempeutics’ stem cell drug, Stempeucel receives European Orphan Drug …pharmabiz.com Stempeutics receives ODD in the European Union for its novel stem cell drug …Equity Bulls |
ABC News |
Devon Still’s Daughter Leah ‘Doing Better’ After Stem Cell Transplant Complication
ABC News The daughter of Cincinnati Bengals defense tackle Devon Still was doing better after suffering a complication in her stem cell transplant, her father said. Still, 25, on Monday posted a photo of himself and his 5-year-old daughter, Leah, to Instagram … NFL’s Devon Still shares photo of daughter Leah after stem cell complicationDaily Mail Dad sends Instagram that his adult stem cell recipient daughter has rallied …National Right to Life News FanSided: Leah Still has complication with stem cell transplantRapid News Network |
Livemint |
Stempeutics eyes late-stage trial waiver for stem–cell drug
Livemint Stempeucel, made from stem cells from bone marrow, is used to treat a rare condition of reduced blood flow to limbs from Buerger’s disease. Roughly 2 million Indians suffer from this disease. “Now that we have completed phase two trials on 120 patients … Stempeutics’ stem cell drug, Stempeucel receives European Orphan Drug …pharmabiz.com Stempeutics Receives Orphan Drug Designation (ODD) in the European Union …PR Newswire (press release) Stempeutics’ Stempeucel gets Orphan Drug status in EuropeMoneycontrol.com |